DualDur reagent and method was developed by a number of laboratory specialists to provide a reliable diagnosis for Lyme borreliosis.
The basic idea, dark-field microscopy has been used to investigate other spirochetes for over a century.
However, microscopy is not suitable to investigate Borrelia in untreated fresh blood. It was a long way to work out the reagent and method until DualDur became a diagnostic method.
We carried out 40,000 investigations with DualDur, while carefully observing and recording clinical symptoms, and performing 110,000 serological tests to back up the diagnosis.
DualDur can be used in standard laboratory diagnostics as a complementary method. With the support of the European Commission’s Horizon 2020 programme, we are currently running clinical testing. The preliminary results are promising, and we hope to be able to make this screening test available at the laboratories in Europe.